Edges in Network
| Network | GSE16391_egf1520 - GSE16391 - SiGN-BN HC+Bootstrap |
| Network Description | GGI: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial |
| Node | CDH22 |
| Upstream (Parents) |
|---|
| (<<) ATN1 → CDH22 |
| (<<) CEND1 → CDH22 |
| (<<) E2F4 → CDH22 |
| (<<) EXOC3L2 → CDH22 |
| (<<) IL23A → CDH22 |
| (<<) NDOR1 → CDH22 |
| (<<) RPS12 → CDH22 |
| (<<) SLC34A3 → CDH22 |
| Downstream (Children) |
|---|
| CDH22 → CDH24 (>>) |
| CDH22 → CHAC1 (>>) |
| CDH22 → CTRB2 (>>) |
| CDH22 → DSCAM (>>) |
| CDH22 → GPX2 (>>) |
| CDH22 → HLA-A (>>) |
| CDH22 → INE1 (>>) |
| CDH22 → KRT75 (>>) |
| CDH22 → LRCH4 (>>) |
| CDH22 → PPP3CC (>>) |
| CDH22 → STX12 (>>) |
| CDH22 → T (>>) |
| CDH22 → TAF1A (>>) |
| CDH22 → UCA1 (>>) |
| CDH22 → WNT6 (>>) |
| CDH22 → ZNF579 (>>) |
